| Literature DB >> 31593097 |
Mahammad M Davudov1,2, Iraj Harirchi1, Ali Arabkheradmand1, Ata Garajei1, Habibollah Mahmudzadeh1, Mohammad Shirkhoda1, Maziar Motiee-Langroudi1, Zoheir Mirzajani1,2, Jayran Zebardast1, Ali Montazeri3.
Abstract
This cross-sectional study aimed to assess and compare quality of life in patients with advanced oral cavity tumors after mandibular resection in 3 groups (no reconstruction, reconstruction with plate, and reconstruction with flap) at the Cancer Institute, affiliated to Tehran University of Medical Sciences. Quality of life was measured using the European Organization for Research and Treatment of Cancer core quality of life questionnaire and European Organization for Research and Treatment of Cancer head and neck cancer-specific quality of life questionnaire-35 items. The comparison was tested using Kurskal-Wallis analysis. All 120 patients were entered into the study. The mean age of patients was 48.5 (standard deviation = 18.1) years. Patients presented with advanced stage of the disease and underwent mandibular resection with no reconstruction (n = 40), reconstruction with plate (n = 41), and reconstruction with flap (n = 39). The findings showed that in general, there were no statistically significant differences in quality of life among 3 groups except for speech problem (P = .4), dry mouth (P = .03), and feeling ill (P = .04). Although there were no significant differences in quality of life among patients in 3 groups, overall patients who received reconstruction with flap reported better functioning and fewer symptoms. Those who did not receive any reconstruction reported the worse conditions.Entities:
Mesh:
Year: 2019 PMID: 31593097 PMCID: PMC6799791 DOI: 10.1097/MD.0000000000017431
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
The characteristics of study samples.
Quality of life among study samples as measured by the European Organization for Research and Treatment of Cancer core quality of life questionnaire (EORTC QLQ-C30).
Quality of life among study samples as measured by the European Organization for Research and Treatment of Cancer head and neck cancer-specific quality of life questionnaire-35 items (EORTC QLQ-H&N35)∗.